January 2019

This year was very exciting for ETAP-Lab and we would like to share with you some of the 2018 major achievements: A new atopic dermatitis model, the DNCB-induced model in Balb/c mice, has been developed with effective studies already in progress. New studies for the account of TEMESIS have been performed showing remarkable effects of their lead TEM1657 drug candidate on Psoriasis and results have been presented in different congresses. Different formulations of their product remaining to be characterized. Jean-François